Insulin receptor substrate (IRS) 1 and 2 are downstream signaling proteins that influence breast pathophysiology. IRS-1 promotes carcinoma cell proliferation; whereas IRS-2 regulates cell motility, invasion, and glycolysis. Our lab has shown that distinct cellular localization of IRS-2 also plays a role in carcinoma cell Immunohistochemistry for IRS-1/-2 was performed. Specific criteria were used to evaluate IRS staining patterns. Follow-up data, ranging from 3-6 years, was available. Statistical analysis was performed to correlate staining patterns of IRS-1/-2 with the three RS groups. IRS-1 staining, predominantly nuclear, did not significantly correlate with RS (P=.5645). IRS-2 expression patterns did show statistical significance amongst the three RS groups (P=.0371). Tumors with intermediate and low RS were more likely to exhibit punctate and diffuse cytoplasmic expression of IRS-2, and cell membrane expression was uncommon in this group. Expression and cellular localization of IRS proteins play an important role in breast cancer cell biology, and expression patterns for IRS-2 do demonstrate a significant correlation with ODX RS. Further studies are required to elucidate the significance of cellular localization of IRS-1/-2 proteins in breast carcinoma cells and their relationship to ODX scores.
Introduction :
The insulin receptor substrate (IRS) adaptor proteins (IRS-1 and IRS-2) are expressed relatively ubiquitously in human tissues and in many cancers. A recent study from our lab examined IRS-1 and IRS-2 expression patterns in approximately 300 invasive breast tumors. 13 Though most tumors exhibited nuclear expression of IRS-1 consistent with previous studies, expression of IRS-2 was variable; exhibiting diffuse cytoplasmic, punctate cytoplasmic, and cell membrane staining patterns. 13 Multivariate analysis revealed a statistically significant decrease in overall survival associated with IRS-2 expression at the cell membrane. 13 The progesterone receptor (PR) negative subset with cell membrane expression demonstrated significantly worse overall survival compared to all other subtypes. 13 Though larger studies with longer follow-up are needed, we concluded that IRS-2 expression patterns in breast tumors, particularly in the setting of PR negativity, could be helpful in determining prognosis and guiding treatment. [14] [15] [16] ; or in some cases at the discretion of the attending oncologist, after review at a multidisciplinary tumor board meeting.
Institutional Review Board (IRB) approval was obtained for this study. Complete data on tumor size, tumor grade, node status, and receptor status were available.
For many patients, follow-up data on recurrence-free survival, overall survival (OS), metastases, and therapy were also available.
Immunohistochemistry
Immunohistochemical studies were performed The sections were counterstained with hematoxylin, dehydrated, and coverslipped with permanent media.
We used the following histologic criteria for IRS-1 and IRS-2 staining patterns which are outlined in a previous study. 13 For IRS-1, a nuclear pattern was defined as diffuse nuclear staining (FIGURE 1). IRS-2 staining patterns were defined using the following criteria: Diffuse cytoplasmic staining was defined as evenly distributed cytoplasmic reactivity (FIGURE 2); punctate cytoplasmic staining was defined as clearly demarcated puncta of staining within the cytoplasm (FIGURE 3); and membrane staining was defined as focal or diffuse membranous staining (FIGURE 4).
Sections of normal pancreas and normal breast tissue
were used for positive and negative controls. The pathologists assessing staining patterns were blinded to the tumor recurrence score and all other data at the time of assessment.
Imaging
Light microscopy was performed using a Nikon Eclipse E400 microscope (Nikon Inc., Melville, NY). 
Statistical Analysis
Statistical correlation for IRS-1 and recurrence score was done using contingency analysis and t-test;
and correlation for IRS-2 and recurrence score was done using contingency analysis and one-way analysis of variance (ANOVA). The REMARK criteria were used for this study. The very low number of patients with significant followup precluded the achievement of statistical significance.
Discussion :
We present the first report of IRS expression patterns in relation to Oncotype DX in ER+ early breast cancer. IRS-1 expression, which was predominantly nuclear when present, did not correlate to RS. However, we did find a significant association between IRS-2 expression patterns and RS. Consistent with a previous study from our group demonstrating a poor prognosis in the setting of IRS-2 expression at the cell membrane, the membrane pattern was least likely to be seen in the low RS group. 13 Unfortunately, due to a very low number of cases with high RS in our study, it is not possible to determine if the high RS group is more likely to demonstrate membrane expression, as expected based on our prior study. 13 We conclude that IRS-2 expression patterns used in conjunction with Oncotype While a prior study demonstrated a role for membrane expression of IRS-2 in disease progression, this expression pattern was relatively rare in our study. 13 There are two likely explanations for this finding. First, this study focused on cases with ER positivity, the population for which Oncotype DX is used in clinical practice, and ER activity upregulates PR expression. 28 Our previous study demonstrated that membrane expression of IRS-2 was statistically more likely in the setting of PR negativity, and so it is unlikely to occur in a predominantly hormone receptor positive study population. 13 Second, there were relatively few high RS cases in this study, which based on our previous study, is the subgroup expected to have the highest rates of IRS-2 expression at the cell membrane. 13 The high rate of punctate IRS-2 expression in our study was also unexpected. Previous work demonstrated that there was no significant relationship between the punctate expression pattern, hormone receptor status, or clinical outcomes. 13 Electron microscopy could be used to determine the specific subcellular localization responsible for this expression pattern, and a larger study might explore this expression pattern in the setting of intermediate RS where it could potentially have more prognostic value than in the population as a whole. The diffuse pattern was also found more frequently than expected, likely due to the high rate of hormone receptor positivity in this study, as this pattern is more likely to be seen in hormone receptor positive tumors with a relatively better prognosis. 13 Work from our group and others has shown a role for IRS-2 in breast carcinoma cell motility and invasion, 
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